1) To understand the different tauopathies for which tau therapies are being developed.

2) To understand the role of biomarkers in precision drug development.

3) To understand master protocol clinical trial designs including basket and umbrella trials.

Session date: 
10/24/2025 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Dr. Adam Boxer